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Background/aim: Microcalcifications are generally accepted as highly specific for thyroid malignancy, especially for papillary thyroid
carcinoma (PTC). The aim of this study was to determine the significance of microcalcification within nodules that were classified as
being of “indeterminate cytology” (IC) according to fine-needle aspiration biopsy.
Materials and methods: Patients who underwent thyroidectomy between January 2010 and 2013 were included in the study. Nodules
identified as “atypia/follicular lesion of undetermined significance”, “follicular neoplasm/suspicious for follicular neoplasm”, or
“suspicious for malignancy” were categorized as IC. Patients were subcategorized depending on the presence of microcalcification
(Group 1) or its absence (Group 2). The relationship between microcalcification and PTC was evaluated in the IC group retrospectively.
Results: Indeterminate cytology was detected in 135 (28.5%) of 473 patients. Microcalcification was detected in 27 (20%) of 135 nodules
and classified as Group 1, while the remaining 108 (80%) patients were classified as Group 2. According to the final pathology results,
PTC was diagnosed in 13 of 27 (48.1%) patients in Group 1 and 29 of 108 (26.8%) patients in Group 2. A statistically significant relation
between microcalcification and malignancy was determined in the IC group (P < 0.05).
Conclusion: Surgery might be considered primarily for patients harboring nodule(s) with IC accompanied by microcalcification due
to increased risk of PTC.
Key words: Thyroid malignancy, microcalcification, indeterminate cytology

1. Introduction
Palpable thyroid nodules are present in 5% to 10% of the
population (1), and the probability of nodule detection
increases with ultrasound examination, which is the
most sensitive diagnostic test to detect thyroid nodules.
Microcalcification (MC) is encountered more with
papillary thyroid carcinoma (PTC) than other thyroid
diseases (2). The presence of MC is a significant ultrasound
finding that increases the malignant risk of nodules (3).
Fine-needle aspiration biopsy (FNAB) has 70% sensitivity
and 96% specificity for diagnosis of thyroid nodules (4).
The Bethesda System (BS) has been a widely accepted
scoring system regarding prediction of the cancer risk
of thyroid nodules since 2007 (5). The BS has led to the
standardization of FNAB reports based on six diagnostic
categories. Categories located in the “indeterminate
cytology” (IC) group have a wide spectrum for the
* Correspondence: draliozemir@hotmail.com

probability of PTC that varies from 15% to 75%. In this
study we aimed to determine the predictive value of the
presence of MC in thyroid nodules with an indeterminate
FNAB report.
2. Materials and methods
This retrospective study was approved by the Scientific
Ethics Committee of the İstanbul Medeniyet University
School of Medicine. The study included 473 consecutive
patients (391 women and 82 men) who underwent
thyroidectomy at our institution between January 2010
and January 2013. Indications for thyroidectomy were risk
of malignancy, compressive symptoms, thyrotoxicosis,
and cosmetic reasons. Patient charts were reviewed for
clinical and ultrasound findings and FNAB reports.
Ultrasonography was used to examine the nodules
within 1 month before thyroidectomy. FNAB was
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performed by radiologists that specialized in thyroid
ultrasonography. Cytological diagnosis was made based
on the BS by pathologists who had experience in thyroid
cytopathology. Patients whose final pathology report
revealed nonpapillary thyroid cancers and who had a
cystic nodule defined as more than 90% of the nodule
being cystic were excluded from the study. According to
the Bethesda classification, nodules defined as “atypia
or follicular lesion of undetermined significance” (AUS/
FLUS), “follicular neoplasm/suspicious for a follicular
neoplasm” (FN/SFN), or “suspicious for malignancy
(SM)” were included in the IC group. Presence of MC was
revealed in ultrasound examination. MC was defined as
echogenic foci of calcification of less than 1 mm at the
longest diameter. Patients were subcategorized into two
groups: those with nodules with MC were categorized as
Group 1 and those without MC as Group 2. Findings were
compared statistically between these groups.
Statistical analysis was performed using the Pearson
chi-square test and the Fisher test with SPSS 20.0. P < 0.05
was considered statistically significant. The sensitivities
and specificities of MC existence were determined to
diagnose PTC.

3. Results
The mean age of 473 patients was 49.9 ± 12.4 years (range:
17–83 years), and the male-to-female ratio was 1:4.8
(82:391). All nodules were classified according to the BS
(Table 1). One hundred and thirty-five (28.5%) of them
were categorized in the IC group according to FNAB
reports with a 31.2% malignancy rate. The AUS/FLUS,
FN/SFN, SM, and benign categories were assigned to
14.2%, 6.3%, 8%, and 68.4% of the FNABs respectively
with 13.4%, 33.3%, 47.9%, and 7.7% malignancy rates,
respectively. Papillary thyroid cancer was diagnosed in 73
(15.4%) of 473 patients.
Ultrasound findings of patients were reviewed
regarding the existence of MC, which was detected
in 95 (20.1%) of nodules, and 24 (25.3%) of these
were malignant, while only 12.9% (49/378) of nodules
were malignant in Group 2 (Table 2). Malignancy
was detected as being significantly higher in cases of
existence of MC within nodules than in nodules without
MC (P = 0.003). The presence of MC within a nodule
had 32.9% sensitivity, 82.3% specificity, 25.3% positive
predictive value, and 86.1% negative predictive value for
the prediction of PTC.

Table 1. Comparison of FNAB results and final histologic evaluation of surgical specimens.
Final
pathology

Benign
(n = 400)

Malignant
(n = 73)

Total
(n = 473)

DC-I (nondiagnostic)

11 (91.7%)

1 (8.3%)

12 (2.5%)

DC-II (benign)

299 (92.3%)

25 (7.7%)

324 (68.4%)

IC

93 (68.8%)

42 (31.2%)

135 (28.5%)

- DC- III (AUS/FLUS)

58 (86.6%)

9 (13.4%)

67 (14.2%)

- DC-IV (FN/SFN)

20 (66.6%)

10 (33.3%)

30 (6.3%)

- DC-V (SM)

15 (39.5%)

23 (47.9%)

38 (8%)

DC-VI (malignant)

-

2 (100%)

2 (0.4%)

Bethesda
classification

DC: Diagnostic category, IC: indeterminate cytology, AUS/FLUS: atypia/follicular lesion of undetermined
significance, FN/SFN: follicular neoplasm/suspicious for a follicular neoplasm, SM: suspicious for malignancy.
Table 2. Comparison of malignancy rate due to the presence of microcalcification.
Benign
(n = 400)

Malign
(n = 73)

Group 1 (%)

71 (74.7%)

24 (25.3%)

Group 2 (%)

329 (86.1%)

49 (12.9%)

Pearson chi-square test, *P < 0.05.

1720

P-value
0.003*

ÖZEMİR et al. / Turk J Med Sci
Diagnostic categories were compared regarding
existence of calcification associated with PTC (Table 3). All
categories were separated into two subgroups in terms of
the presence of MC. Twenty-seven of the patients that were
categorized as IC were in Group 1, while 108 were in Group
2. The malignancy rate of IC nodules for these groups was
48.1% (13/27) and 26.8% (29/108), respectively. The odds
ratio was detected as 1.79 for the risk of papillary cancer.
Presence of MC in nodules with IC revealed a significantly
higher rate of papillary cancer than nodules without MC
(P = 0.033). Papillary cancer was detected in 16.6% (9/65)
of the patients with benign cytology and in Group 1, and
in 7.9% (19/259) of the patients in Group 2. Presence of
MC increased the risk of papillary cancer in all thyroid
nodules. However, benign, malignant, or nondiagnostic
nodules did not reveal a statistically significant difference
in terms of the association of PTC with the presence of
nodular MC.
4. Discussion
A thyroid nodule is defined as a discrete lesion within
the thyroid gland that is radiologically distinct from the
surrounding parenchyma (6). Controversial issues about
the terminology and morphologic criteria of thyroid
nodules caused the formation of the Bethesda System
for Reporting Thyroid Cytopathology (BSRTC). This
system led to standardization of FNAB reports based
on six diagnostic categories regarding the clarity of
interdisciplinary communication: I = nondiagnostic,
II = benign, III = atypia of undetermined significance,
or follicular lesion of undetermined significance, IV =
follicular neoplasm/suspicious for a follicular neoplasm, V
= suspicious for malignancy, and VI = malignant (5). The
BSRTC has proven to be an effective classification to guide
the treatment options of thyroid nodules (7). Diagnostic

categories III, IV, and V according to the BSRTC are
grouped as IC. FNABs yield IC diagnosis in 15% to 30%
of all biopsies (8).
The clinical and radiological findings supported by
pathological parameters have great significance to predict
PTC (9–11). Ultrasound examination of the thyroid gland
is widely used to detect the existence of calcification in
nodules preoperatively (4,12). Several studies showed that
various ultrasound characteristics such as predominantly
solid texture, hypoechogenicity, vascularity pattern of the
nodule, presence of MC, and absence of a halo are considered as indications that the nodule is more likely to be
malignant (13–15). The presence of MC is one of the most
significant ultrasound findings to evaluate the malignancy
risk of thyroid nodules. The clinical significance of calcification and the molecular mechanism that is responsible
for calcification in PTC is still uncertain (2). The rapid
proliferation of cancer cells may lead to necrosis, resulting in calcium deposits (16). Histopathologically, calcifications can be seen as psammoma bodies and dystrophic
calcifications, or psammoma bodies and stromal calcifications (2). Psammoma bodies are basophilic, laminated,
spherical accretions that are specific for PTC, although
they are occasionally detected in benign thyroid nodules
(17,18). Although calcification can be present in both benign and malignant thyroid lesions, a remarkable association between PTC and MC has been consistently noted in
several reports (4,12,17,19). Other types of calcifications
such as macrocalcifications, coarse, eggshell, and rim calcifications were thought to be more common in benign
thyroid nodules than PTC (4). Contrarily, other calcification patterns can also be observed in nodules with PTC.
Wang et al. (20) reported MC in 53.5% of patients with
PTC. Sieberling et al. (4) found that macrocalcifications
were equally distributed between benign and malignant

Table 3. Comparison of malignancy rates of groups according to diagnostic categories of fine-needle aspiration biopsy.
Final
pathology

Malignancy rates % (malign n/total n)
Group-1
(n = 95)

Group-2
(n = 378)

Total
(n = 473)

P-value

Indeterminate cytology

48.1% (13/27)

26.8% (29/108)

31.2% (42/135)

0.033*

AUS/FLUS

42.9% (3/10)

10.5% (6/57)

13.4% (9/67)

0.125α

FN/SFN

33.3% (3/9)

33.3% (7/21)

33.3% (10/30)

0.669α

SM

87.5% (7/8)

53.3% (16/30)

60.5% (23/38)

0.114α

Benign

16.6% (9/65)

7.9% (19/259)

9.5% (28/324)

0.095

Malignant

100% (1/1)

100% (1/1)

100% (2/2)

0.350

Nondiagnostic c.

50% (1/2)

0% (0/10)

(1/12)

0.025

FNAB

AUS/FLUS: Atypia/follicular lesion of undetermined significance, FN/SFN: follicular neoplasm/suspicious for a follicular neoplasm,
SM: suspicious for malignancy. *: Pearson chi-square test, α: Fisher exact test.
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lesions. The same study revealed that 62% of patients with
MC had malignant nodules. A further study reported that
the existence of MC in a solid nodule increases the patient’s
cancer risk by about threefold (3). Our study revealed that
PTC risk increases approximately 1.8-fold for patients in
the IC category accompanied with MC. Presence of MC in
a thyroid nodule has been shown to have a high predictive
value (42%–94%) but a low sensitivity rate (26%–59%) in
the diagnosis of PTC (10,21,22). In our study, the presence
of MC within the nodules has been shown to reveal 32.9%
sensitivity, 82.3% specificity, 25.3% positive predictive value, and 86.1% negative predictive value in the diagnosis of
PTC. Presence of MC within a nodule increased the rate
of PTC from 12.9% to 26.1%. On the other hand, the PTC
rate significantly increased from 12% to 46% in cases with
MC accompanied by IC.

To date, few reports have assessed the clinical significance of MC in PTC, particularly in the IC category. This
study focused primarily on the importance of the presence
of MC in patients with an IC report. In conclusion, during
the diagnostic assessment of thyroid nodules, other risk
factors for PTC including the presence of a history of exposure to external radiation, male sex, young age, presence
of enlarged cervical lymph nodes, and ultrasound findings
of the nodule such as solid texture, hypoechogenicity, vascularity, and absence of a halo should be evaluated as well
as the presence of MC before making the decision for surgery. However, the presence of MC is an important finding
to predict PTC, especially for nodules with IC. Therefore,
surgery might be considered primarily for nodules detected to represent the combination of IC and the presence of
MC.
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